Akshaya Ravishkumar L, Rohini Muthukumar, Selvamurugan Nagarajan
Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur 603203, Tamil Nadu, India.
Curr Cancer Drug Targets. 2020;20(10):757-767. doi: 10.2174/1568009620666200712144103.
Breast cancer (BC) is the cardinal cause of cancer-related deaths among women across the globe. Our understanding of the molecular mechanisms underlying BC invasion and metastasis remains insufficient. Recent studies provide compelling evidence on the prospective contribution of noncoding RNAs (ncRNAs) and the association of different interactive mechanisms between these ncRNAs with breast carcinogenesis. MicroRNAs (small ncRNAs) and lncRNAs (long ncRNAs) have been explored extensively as classes of ncRNAs in the pathogenesis of several malignancies, including BC.
In this review, we aim to provide a better understanding of the involvement of miRNAs and lncRNAs and their underlying mechanisms in BC development and progression that may assist the development of monitoring biomarkers and therapeutic strategies to effectively combat BC.
These ncRNAs play critical roles in cell growth, cell cycle regulation, epithelialmesenchymal transition (EMT), invasion, migration, and apoptosis among others, and were observed to be highly dysregulated in several cancers. The miRNAs and lncRNAs were observed to interact with each other through several mechanisms that governed the expression of their respective targets and could act either as tumor suppressors or as oncogenes, playing a crucial part in breast carcinogenesis.
乳腺癌(BC)是全球女性癌症相关死亡的主要原因。我们对BC侵袭和转移的分子机制的理解仍然不足。最近的研究为非编码RNA(ncRNAs)的潜在作用以及这些ncRNAs之间不同的相互作用机制与乳腺癌发生的关联提供了令人信服的证据。微小RNA(小ncRNAs)和长链非编码RNA(lncRNAs)作为ncRNAs的类别,已在包括BC在内的几种恶性肿瘤的发病机制中得到广泛研究。
在本综述中,我们旨在更好地理解miRNAs和lncRNAs及其潜在机制在BC发生发展中的作用,这可能有助于开发监测生物标志物和治疗策略,以有效对抗BC。
这些ncRNAs在细胞生长、细胞周期调控、上皮-间质转化(EMT)、侵袭、迁移和凋亡等过程中发挥关键作用,并且在几种癌症中被观察到高度失调。miRNAs和lncRNAs被观察到通过多种机制相互作用,这些机制控制着它们各自靶标的表达,并且既可以作为肿瘤抑制因子也可以作为癌基因发挥作用,在乳腺癌发生中起关键作用。